(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of -17.42% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.35%.
Quidelortho's revenue in 2023 is $3,266,000,000.On average, 3 Wall Street analysts forecast QDEL's revenue for 2023 to be $188,170,991,369, with the lowest QDEL revenue forecast at $183,328,523,048, and the highest QDEL revenue forecast at $193,590,993,851. On average, 3 Wall Street analysts forecast QDEL's revenue for 2024 to be $156,778,444,996, with the lowest QDEL revenue forecast at $72,585,483,015, and the highest QDEL revenue forecast at $199,335,210,871.
In 2025, QDEL is forecast to generate $90,800,021,954 in revenue, with the lowest revenue forecast at $90,800,021,954 and the highest revenue forecast at $90,800,021,954.